NCT06459986

Brief Summary

Today, surgery in an ambulatory setting is preferred for many reasons. Total hip and knee arthroplasty (THA and TKA) are now procedures where patients can be sent home on the same day of the surgical procedure. However, this requires substantial knowledge of factors affecting the length of hospital stay. In this prospective, observational cohort study, we will investigate factors that affect the duration of spinal anaesthesia which is often used in THA and TKA. The aim is to gather enough data to be able to determine how local anaesthetic volume and dose affect the duration of spinal anaesthesia. This will enable us to decide whether spinal anaesthesia is a good option when performing TKA and THA in an ambulatory setting.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Jun 2024

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jun 2024Dec 2026

Study Start

First participant enrolled

June 3, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

June 4, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 14, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

2.2 years

First QC Date

June 4, 2024

Last Update Submit

January 15, 2026

Conditions

Keywords

Regional anaesthesiaSpinal anaesthesia

Outcome Measures

Primary Outcomes (2)

  • Duration of spinal anasthesia 1

    Time from subarachnoid LA administration to Bromage score \< 3

    12 hours

  • Duration of spinal anaesthesia 2

    Time from subarachnoid LA administration to Bromage score = 1

    12 hours

Study Arms (1)

Spinal anaesthesia

Participants scheduled for orthopaedic surgery performed in spinal anaesthesia with or without sedation

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult participants scheduled for elective surgical procedures performed in spinal anaesthesia

You may qualify if:

  • Scheduled for elective orthopaedic surgical procedures performed in spinal anaesthesia
  • ASA 1-4.

You may not qualify if:

  • Age \< 18 years
  • Anticoagulant medication therapy not paused according ESAIC/ESRA 2022 guidelines
  • Local infection at the lumbar puncture site
  • Bleeding disorder
  • Unable to cooperate with the spinal anaesthesia procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Anæstesiologisk Afd

Hillerød, 3400, Denmark

RECRUITING

Aleris-Ringsted

Ringsted, 4100, Denmark

RECRUITING

MeSH Terms

Conditions

Musculoskeletal Diseases

Study Officials

  • Kai HW Lange, MD

    Dept. of Anaesthesiology, Nordsjællands Hospital Hillerød, Denmark

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2024

First Posted

June 14, 2024

Study Start

June 3, 2024

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations